CBD, one of the more than 100 chemicals in cannabis, is emerging as a popular wellness ingredient. The plant extract, often consumed as an oil under the tongue, is now the featured ingredient in high-end products including coconut oil, body lotion, face serum, olive oil, jam, bath scrub, cold-brew coffee, sports salve, lip balm, infused water, gummy snacks and dog treats. Products' prices vary but may cost about triple what their CBD-less counterparts do.
Be careful to check the nutritional info. On back of bottles. While some brands boast of high mg.s that is for the whole bottle. I use a brand that is 2 oz. 100 mg. Pet dose. A dose is 3 drops. I’ve seen some boast of 700 mg. Or more, but you read on back that a dose is 20 drops for 10 mg. Of help oil. That 700 is the whole 1oz. Bottle and cost twice what I pay for a 2 is bottle.
It is for this reason that all the finished hemp goods that you see for sale in America, from food products to clothing to building materials, are part of an imported hemp industry that has surpassed $688 million annually. The size of this import industry is one of the major catalysts for hemp legalization in the U.S. As a renewable source of a range of products, hemp provides an exciting new step in American agriculture.
The Alchemist’s Kitchen and Clover Grocery are high-end stores that cheerfully tell customers where they source their products from and only stock brands with similarly transparent sourcing. This CBD usually comes from cannabis plants farmed in Colorado or Oregon, or, increasingly, states not normally associated with the cannabis trade. EarthE CBD, a prominent online seller of CBD products, for example, sources from local farms in New Jersey; it also publishes lab results on its website showing that its products have been tested to have no THC and the amount of CBD the company says they should have.
Additionally, as many as 26/46 samples (57%) had a THC content > 1%, with one sample peaking at 57.5%. In 18/46 samples (39%) the oil contained virtually only THC (with CBD < 0.1%). Although many of the samples analyzed were purposely made to contain a high THC content, it is unclear whether oil consumers are always aware they are consuming THC, and thereby exposing themselves to the adverse effects of this psychotropic compound, such as intoxication, panic attacks, or disorientation. It should be noted that although the exact legal status of CBD may be debatable, THC-rich extracts are strictly prohibited in virtually all countries.
“If you use a tiny amount of psilocybin, it still does something,” says Blessing. “Microdosing with psilocybin still has effects biologically, but there isn’t any evidence that low doses of CBD, like 5 mg, do anything at all.” The only study I could find indicating that low doses of CBD have an effect concluded that a rare form of childhood epilepsy called Lennox-Gastaut syndrome is treatable using 10 mg of CBD. For anxiety in adults? Nothing.
This has been the year medical cannabis hit the mainstream. The government has announced that it is relaxing laws on when cannabis medicines can be prescribed by doctors, following high-profile cases such as that of Billy Caldwell, the 13-year-old boy hospitalised by his epileptic seizures after he was denied legal access to the cannabis oil that helps control them. Meanwhile a new generation of cannabis medicines has shown great promise (both anecdotally and in early clinical trials) in treating a range of ills from anxiety, psychosis and epilepsy to pain, inflammation and acne. And you don’t have to get stoned to reap the health benefits.
In September 2018, following its approval by the FDA for rare types of childhood epilepsy, Epidiolex was rescheduled (by the Drug Enforcement Administration) as a Schedule V drug to allow for its prescription use. This change applies only to FDA-approved products containing no more than 0.1 percent THC. This allows GW Pharmaceuticals to sell Epidiolex, but it does not apply broadly and all other CBD-containing products remain Schedule I drugs. Epidiolex still requires rescheduling in some states before it can be prescribed in those states.
Cannabidiol (CBD) is one of dozens of non-psychoactive cannabinoids found in the hemp plant. Cannabidiol, and all the other cannabinoids, were patented by the United States Government in 2003 as neuroprotectants and antioxidants (Patent No. 6,630,507). Cannabinoids are characterized by their ability to act on the cannabinoid receptors that are found throughout the body. CBD and other cannabinoids are naturally occurring compounds that display potent anti-inflammatory and pain-relieving properties. They can promote the body’s healthy regulation of the central nervous, immune, and endocannabinoid systems.